Who makes Leukoreduced and irradiated?

Leukoreduced and irradiated is developed by University of Washington.

What development phase is Leukoreduced and irradiated in?

Leukoreduced and irradiated is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

Leukoreduced and irradiated

University of Washington · FDA-approved active Biologic Quality 1/100

At a glance

Generic name	Leukoreduced and irradiated
Sponsor	University of Washington
Modality	Biologic
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

POOLED Red Blood Cells Prepared From Pooling 5 Leukoreduced, Irradiated RBC Units (PHASE1)
Immunomodulation Following Transfusion (PHASE4)
Adverse Effects of RBC Transfusions: A Unifying Hypothesis (PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Leukoreduced and irradiated CI brief — competitive landscape report
Leukoreduced and irradiated updates RSS · CI watch RSS
University of Washington portfolio CI